CD274 and neoplasm: Petit et al. showed that T cell-mediated targeted delivery of an anti-PD-L1 VHH outperformed an anti-PD-L1 conventional antibody in inhibiting tumor growth, related to its higher tumor penetration in MC38 tumor-bearing mice [113].